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Exchange of N-CoR Corepressor and Tip60
Coactivator Complexes Links Gene Expression
by NF-B and -Amyloid Precursor Protein
nuclear receptors is mediated by the nuclear receptor
corepressor (N-CoR) (Horlein et al., 1995) and the closely
related silencing mediator for retinoic acid and thyroid
hormone receptor (SMRT) (Chen and Evans, 1995).
N-CoR and SMRT contain two nuclear receptor interac-
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tion domains and at least three repressor domains thatDepartment of Molecular Medicine
can transfer their active repression function (Perissi et2 Department of Medicine
al., 1999). N-CoR/SMRT appears to be required for re-Division of Endocrinology and Metabolism
pression by thyroid hormone receptor (T3R) and retinoic3 Department of Neuroscience
acid receptor (RAR) and for the function of estrogen4 Department of Cellular and Molecular Medicine
receptor antagonists in some cell types. While the ac-School of Medicine
tions of N-CoR/SMRT are linked to recruitment of a Sin3/University of California, San Diego
HDAC1, 2 complex for nuclear receptors (Heinzel et al.,9500 Gilman Drive
1997; Nagy et al., 1997), N-CoR/SMRT exerts effects onLa Jolla, California 92093
many other classes of transcription factors (reviewed in
Glass and Rosenfeld, 2000).
Multiple distinct N-CoR- and SMRT-containing com-Summary
plexes have been purified and characterized biochemi-
cally. One high-affinity complex purified from HeLaDefining the molecular mechanisms that integrate di-
nuclear extracts contains N-CoR/SMRT, histone deacety-verse signaling pathways at the level of gene transcrip-
lase 3 (HDAC3), and transducin -like 1 (TBL1), a WD-tion remains a central issue in biology. Here, we dem-
40 repeat-containing protein (Guenther et al., 2000).onstrate that interleukin-1 (IL-1) causes nuclear
Additional N-CoR/SMRT complex, containing SWI/SNF-export of a specific N-CoR corepressor complex, re-
related proteins, has been described (Underhill et al.,sulting in derepression of a specific subset of NF-B-
2000). Recently, Zhang et al. (2002) reported GPS2 asregulated genes, exemplified by the tetraspanin KAI1
another component of the N-CoR complex.that regulates membrane receptor function. Nuclear
Cytokines, including IL-1, have been implicated asexport of the N-CoR/TAB2/HDAC3 complex by IL-1
mediators and modulators of immune activation, cellis temporally linked to selective recruitment of a Tip60
death, and inflammatory processes that have beencoactivator complex. Surprisingly, KAI1 is also directly
shown to be involved in neurodegenerative conditionsactivated by a ternary complex, dependent on the ace-
including Alzheimer’s disease (reviewed in Mrak andtyltransferase activity of Tip60, consisting of the pre-
Griffin, 2000), and inappropriate regulation of NF-B issenilin-dependent C-terminal cleavage product of the
directly involved in neurodegenerative disease (re-amyloid  precursor protein (APP), Fe65, and Tip60,
viewed in Mattson and Camandola, 2001). When stimu-identifying a specific in vivo gene target of an APP-
lated by IL-1, IL-1 receptor-associated kinase (IRAK)dependent transcription complex in the brain.
activates the TNF receptor-associated factor 6 (TRAF6),
which activates the TAK1/TAB1/TAB2 complex in theIntroduction
cytosol (Shibuya et al., 1996; Takaesu et al., 2000), which
is required for IL-1-mediated NF-B and c-Jun N-ter-The ability to integrate multiple signaling pathways to
minal kinase (JNK) activation. Activation of NF-B oc-
achieve unique responses is a critical requirement for
curs following upregulation of the expression of proin-
development and homeostasis in all metazoans. One
flammatory genes in the nucleus (reviewed in Baldwin,
level at which this type of regulation occurs is in the 1996). NF-B p65 functions as a transcriptional activator
nucleus, based on regulation of the multiple coactivator for p50-p65 heterodimers; conversely, p50 homodimers,
and corepressor complexes that modulate gene tran- which lack an activation region, are detected in the nu-
scription (reviewed in Glass and Rosenfeld, 2000). For cleus and appear to function as repressors (reviewed
example, an interrelationship between distinct signaling in Silverman and Maniatis, 2001).
pathways has been defined for nuclear receptors and -amyloid precursor protein (APP) is a ubiquitously
nuclear factor-B (NF-B), based on transrepression of expressed cell surface protein from which the activities
NF-B by nuclear receptors and the linkage of inflamma- of - and -secretase generate the amyloid -peptide
tory responses to nuclear receptor repression (reviewed (A). A is deposited in amyloid plaques in brains of
in McKay and Cidlowski, 1999). These interrelationships Alzheimer’s disease individuals (reviewed in Steiner and
raise questions regarding the molecular mechanisms by Haass, 2001), as a component of a progressive neurode-
which control of specific coregulatory complexes affect generative disease. -secretase cleavage not only leads
the transcriptional responses to intra- and extracellular to the generation of A but also results in the liberation
signals. of an intracellular domain of APP (AICD), which has been
Active repression of gene expression by unliganded suggested to potentially function in nuclear signaling.
Recently, Cao and Sudhof (2001) showed that a trimeric
complex consisting of AICD, the APP binding protein5 Correspondence: mrosenfeld@ucsd.edu
6 These authors contributed equally to this work. Fe65, and a Gal-4 fusion of the MYST family acetyltrans-
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Figure 1. Identification of a TAB2/N-CoR/HDAC3-Containing Complex Exhibiting IL-1-Dependent Nuclear Export
(A) Bait plasmid containing repressor domain I of N-CoR interacts with the target plasmid in a yeast two-hybrid system (-galactosidase
units).
(B) Amino acid sequence of TAB2, as predicted by the encoding murine cDNA (GenBank AY093701), with high homology to the human cDNA,
nuclear export signal sequence, and a coiled-coil region indicated.
(C) RNA blot analysis revealed single mRNA species in all tissues evaluated using -actin RNA for normalization.
(D) In vivo association of N-CoR with TAB2 in 293 cells. Cell extracts were immunoprecipitated with anti-N-CoR IgG, and coprecipitated TAB2
was detected with anti-TAB2 IgG. Preimmune IgG was used as a negative control.
(E) Histone deacetylase (HDAC) activity was measured from immunoprecipitates from either preimmune IgG or anti-TAB2 IgG in the absence
or presence of HDAC inhibitor, TSA.
(F) GST interaction assay using in vitro translated [35S]methione-labeled HDAC3, 1, 5, or TBL1 with GST-TAB2 fusion protein, revealing
preferential interaction with HDAC3.
(G) Identification of the TAB2-containing complex from 293 nuclear extract using anti-TAB2 IgG affinity chromatography.
(H) Schematic representation of murine N-CoR showing the location of the repressor domains (RDI, RDII, RDIII) and the nuclear receptor
interaction domains (ID-I, ID-II). GST pull-down assay revealed that segments of N-CoR spanning amino acids 92–393 and 267–549 bind with
TAB2.
(I) TAB2 protein can function as a repressor when fused to GAL4 DNA binding domain under the control of the 3 UAS/tk promoter.
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ferase Tip60 could stimulate transcription of an UAS- nuclear extracts. Consistent with the resulting immuno-
precipitation and GST pull-down experiments, neitherdependent reporter.
In this manuscript, we identify a specific N-CoR/TAB2/ HDAC1, HDAC2, HDAC4, HDAC5, nor TBL1 showed sig-
nificant binding (Figure 1G and data not shown); how-HDAC3 complex that exhibits IL-1 signal-dependent
export from nucleus to cytoplasm, and we identify the ever, there may be additional components of this N-CoR
complex. To investigate the domains of N-CoR that weretetraspanin KAI1/CD82 as a specific target for repres-
sion by this complex. The consequence of this IL- capable of direct physical interactions with TAB2, we
performed interaction assays using GST-fused TAB21-dependent nuclear export is to relieve repression
by a subset of N-CoR-dependent transcription factors. and in vitro translated segments of N-CoR (Perissi et
al., 1999). As shown in Figure 1H, N-CoR fragmentsNuclear export of the N-CoR/TAB2 complex, in response
to IL-1, is associated with recruitment of a Tip60-con- containing amino acid residues 92–393 and 267–549
clearly bound TAB2, identical to those regions that inter-taining complex to the KAI1 promoter. Interestingly, a
second proposed Tip60 complex consisting of the AICD, act with HDAC3 (Wen et al., 2000). Finally, TAB2 was
found to harbor intrinsic corepressor properties, as aFe65, and Tip60 can dismiss the N-CoR corepressor
complex in vivo. Activity of this Tip60 complex is not GAL4/TAB2 fusion protein caused repression of a UAS/
tk reporter (Figure 1I).dependent on IL-1 but is dependent on the acetyltrans-
ferase function of Tip60. Thus, a subset of NF-B-regu-
lated genes can be activated following export of the IL-1 Signal-Dependent Nuclear Export of N-CoR
along with TAB2N-CoR corepressor complex directly by IL-1 or, alter-
natively, by sufficiently elevated levels of an AICD/Fe65/ Because TAB2 was recently isolated and reported to
function as an IL-1 signaling molecule by activatingTip60 complex in vivo. The activity of this APP complex
supports the model of which the AICD can activate spe- the NF-B pathway (Takaesu et al., 2000), we evaluated
potential effects of IL-1 on N-CoR and TAB2 localiza-cific targets that may be relevant in development and
neurodegeneration. tion. While most, but not all, TAB2 was nuclear in local-
ization in unstimulated cells, when cells were stimulated
by IL-1, TAB2 and N-CoR surprisingly became local-Results
ized in the cytoplasm. However, residual nuclear stain-
ing was observed for both proteins. Merged imagesIdentification of TAB2 as an
N-CoR-Interacting Molecule revealed colocalization in a pattern that mimics the mi-
crotubular pattern of CV-1 cells. A similar result wasTo begin to decipher the potential nuclear integration
events that link specific signaling pathways to broad obtained both in the absence and presence of serum
(Figure 1J and data not shown). A significant relocationprograms of repression, we further investigated whether
specific nuclear receptor corepressor (N-CoR)-con- of HDAC3 to the cytoplasm, but not other HDACs, was
consistently observed (Figure 1K and data not shown).taining complexes were of distinct functional impor-
tance. Using a yeast two-hybrid screening system to Leptomycin B, an inhibitor of nuclear export, com-
pletely blocked the IL-1-induced cytoplasmic appear-search for proteins that directly interact with N-CoR
regulatory domains, we obtained four isolates encom- ance of both N-CoR and TAB2, indicating that this trans-
location is the result of increased nuclear export (Figurepassing distinct regions of a specific DNA from a mouse
embryonic head cDNA library that exhibited a strong 2A). A nuclear export signal sequence (NES) (Fornerod
et al., 1997) was located in the coiled-coil region ofinteraction with repressor domain 1 (RD1) of N-CoR (Fig-
ure 1A). The full-length cDNA encompassed a 2079 nu- TAB2, and site-directed mutations in the NES resulted
in a molecule that was not translocated to the cytoplasmcleotide open reading frame that predicted a 693 amino
acid protein (Figure 1B). This was the murine homolog in response to IL-1, which also blocked export of
N-CoR (Figure 2B). This hypothesis was further evalu-of human TAB2 (Takaesu et al., 2000). RNA blot analysis
revealed a virtually ubiquitous expression, at various ated using a single-cell nuclear microinjection assay,
which showed that injection of anti-TAB2 IgG largelylevels, of a single TAB2 transcript (Figure 1C).
In vivo coimmunoprecipitation assays indicated that blocked translocation of N-CoR in response to IL-1
(injected cells are rhodamine stained, Figure 2C). In con-endogenously expressed TAB2 and N-CoR were pres-
ent in a complex in 293 cells (Figure 1D). Material trast, full-length SMRT was not exported from the nu-
cleus in response to IL-1, although there might be otherimmunoprecipitated by specific, purified anti-TAB2 IgG
contained TSA-sensitive histone deacetylase (HDAC) isoforms that exhibit export (data not shown).
enzymatic activity. Interestingly, TAB2 exhibited a
strong interaction with HDAC3, and only minimal inter- Nuclear Export of N-CoR and TAB2 Is Regulated
by MEKK1actions with HDAC1, HDAC2, HDAC5, or TBL1 by GST
pull-down assay (Figure 1F, and data not shown). Using IL-1-induced phosphorylation of TAB2 has been re-
ported (Takaesu et al., 2000), and treatment with U0126anti-TAB2 IgG immunoaffinity chromatography, we re-
covered a stable N-CoR/TAB2/HDAC3 complex from prevented the nuclear export of N-CoR (Figure 2D), con-
(J) CV-1 cells were maintained in either serum-starved medium (shown) or serum-containing medium (not shown), and exposed to IL-1 for
2 hr. Cells were stained with antibodies directed against the N terminus of N-CoR and the C terminus of TAB2, and the fluorescence-conjugated
secondary antibody was visualized using deconvoluting microscopy. Nuclear staining with DAPI is shown.
(K) Cells were stained with anti-HDAC2 or anti-HDAC3 IgG.
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Figure 2. Identification of the Nuclear Export Signal (NES) and MEKK1 Target Sites on TAB2
(A) CV-1 cells pretreated with leptomycin B (10 ng/ml) for 30 min were examined for effects of IL-1 for 2 hr on localization of N-CoR and
TAB2.
(B) Alignment of NES and block of the nuclear export by mutation of the NES of TAB2. NES sequences are compared with MAPKK and
NGFI-B. Consensus residues are underlined and indicated in “red.” Transiently transfected cells with NES disruption mutant were treated
with IL-1 for 6 hr, and localization of N-CoR- and TAB2-containing NES disruption mutants was examined.
(C) Microinjection of TAB2 IgG, using TRITC-conjugated dextran to mark injected cells prior to IL-1 treatment for 2 hr, largely blocks most
nuclear N-CoR export. Uninjected cells (arrows) show N-CoR export to cytoplasm.
(D) CV-1 cells were pretreated with U0124 (negative control) or U0126 (MEK/MEKK inhibitor) for 30 min, followed by IL-1 treatment for 2 hr.
Localization of N-CoR and TAB2 were examined.
(E) Schematic representation of MEKK and MEK target sites on TAB2. Site-directed mutagenesis was performed to replace serine residues
by alanine residues.
(F) TAB2 holoprotein harboring the indicated MEKK1 target site disruption mutants of TAB2 were transiently transfected, the cells were treated
with IL-1 for 6 hr, and cellular distribution of N-CoR and TAB2 was analyzed by staining with anti-N-CoR IgG and anti-TAB2 IgGs.
sistent with the possibility that the MEK kinase-depen- or indirectly unmasking the NES in TAB2. We found
that overexpressed N-terminally deleted TAB2, whichdent phosphorylation pathway might be involved in me-
diating the nuclear export of N-CoR, perhaps by directly contains the NES, was capable of the IL-1-mediated
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nuclear export along with N-CoR like full-length TAB2 indicating the specificity of the N-CoR/TAB2/HDAC3
complex.(Figure 2E and data not shown). By systematic mutation
Interestingly, with release of the N-CoR complex fromof the serine residues in every consensus MEK and
the promoter, we could not detect the coactivators usu-MEKK site in TAB2 and then transfection to overexpress
ally recruited by nuclear receptors, including the p160each mutant, we found that alanine mutation of only one
factors, CBP/p300, PBP, p/CAF, or Brg1 (Figure 3C andof these sites (S419/423-A) prevented IL-1-induced nu-
data not shown). However, acetylated histones H3 andclear export of N-CoR and TAB2 (Figure 2F). These data
H4, as well as phospho S10 histone H3, were detected,suggest that phosphorylation of the S419/423 site is
suggesting a replacement of the corepressor complexrequired for export, although direct evidence of phos-
by HAT-containing coactivator complex, in concert withphorylation of this site in intact cells has not yet been
the appearance of Pol II (Figure 3C). We therefore testedprovided. Together, these data strongly suggest that
whether members of the MYST family might be re-IL-1 stimulates a covalent modification of TAB2 that
cruited, particularly Tip60, as it was reported to interactpermits function of the NES, causing export of the
with Bcl3 on a yeast two-hybrid screen (Dechend et al.,N-CoR/TAB2/HDAC3 complex.
1999). We documented a transient recruitment of Tip60
to the p50 bound KAI1 promoter following IL-1 treat-Identification of Target Gene, KAI1, Which
ment and loss of the N-CoR complex (Figure 3C), per-Recruits N-CoR and TAB2
haps via interactions with Bcl3, consistent with an initialWhile TAB2 proved not to bind directly to either the
loss of associated corepressors and subsequent recruit-p50 or p65 NF-B component, addition of N-CoR to the
ment of coactivators. Biological relevance was con-mixture of TAB2 and p50 allowed formation of a p50/
firmed by a temporally corresponding induction of KAI1NCoR/TAB2 complex in vitro (Figure 3A). However, no
transcripts observed at 60–90 min by RNA blot analysissuch interaction was detected with the p65 (Figure 3A).
and RT-PCR (Figure 3D). A Tip60 complex, involved inEndogenous p50 could be coimmunoprecipitated with
DNA repair, does not effectively acetylate histone H3either N-CoR or TAB2 from extracts of 293 cells (Figure
on chromatinized DNA (Ikura et al., 2000), raising the3B), indicating their interaction. DNA microarray ap-
question of whether histone acetylation at the KAI1 pro-proaches have identified potential IL-1-stimulated NF-
moter was mediated by Tip60 or by an as yet unidentifiedB target genes (Li et al., 2001), and we chose to first
histone acetyltransferase. Among the components ofinvestigate the KAI1/CD82 gene, which contains a NF-
the purified Tip60 DNA repair complex that could be
B response element, as a possible N-CoR/TAB2/
evaluated (Ikura et al., 2000), we detected TRRAP (FigureHDAC3-repressed target gene. The KAI1/CD82 gene
3C) but not BAF53 or TAP54. While the failure to detectwas first identified as a metastasis-suppressor gene
BAF53 or TAP54 could reflect a limitation of antibodyfor prostatic cancer and possibly for breast and lung
detection, the data is most compatible with recruitmentcancers, and it belongs to a structurally distinct family of
of a specific Tip60 complex on the p50-dependent pro-leukocyte cell surface glycoproteins (Dong et al., 1995)
moter, or the possibility that other components of thereferred to as tetraspanins (Maecker et al., 1997).
Tip60 complex might be dissociated from the complex
In unstimulated or IL-1-treated 293 cells, we de-
rapidly after recruitment to the promoter. To further clar-
tected the continued presence of p50, but not p65, on
ify this issue, we introduced a Tip60 mutant harboring
the KAI1 promoter by chromatin immunoprecipitation
a 2 amino acid mutation that abolished HAT activity
(ChIP) assay (Figure 3C), indicating that this promoter (Ikura et al., 2000) into 293 cells, finding an inhibition of
might recruit p50 homodimers, originally described by histone H3/H4 acetylation and failure to detect Pol II
Baltimore and his colleagues (Fujita et al., 1993). Bcl3, to be recruited on the KAI1 promoter following IL-1
which is functionally related to but distinct from IB, treatment, even though the N-CoR/TAB2/HDAC3 com-
has been reported to preferentially interact with the p50 plex was dismissed (Figure 3E). We suggest that, directly
subunit of NF-B, and both proteins colocalize to the or indirectly, Tip60 is likely to be a required component
nucleus (Fujita et al., 1993). We found that Bcl3 was for gene activation events that include histone H3/H4
detected on the KAI1 promoter, further supporting the acetylation. Consistent with the model of MEKK1-medi-
idea that this promoter recruits a p50 homodimer that ated exchange of corepressors for coactivators, overex-
binds both Bcl3 and a specific N-CoR corepressor com- pression of the S419/423A mutant TAB2 blocks the re-
plex when it is transcriptionally inactive (Figure 3C). lease of the corepressor complex and prevents the
In unstimulated 293 cells, the KAI1 promoter was recruitment of Tip60, Pol II, or histone acetylation after
found to have bound N-CoR, TAB2, and HDAC3, and IL-1 treatment (Figure 3F).
upon stimulation by IL-1, progressive dismissal of all In contrast, NF-B target genes recruiting both p50
three proteins from the promoter was coincident with and p65 in an IL-1 signal-dependent fashion, such as
their nuclear export (Figure 3C). If MEKK1 mediates intracellular adhesion molecule-1 (ICAM-1) and interleu-
N-CoR/TAB2 export, it should exhibit transient associa- kin-8 (IL-8), failed to recruit the N-CoR/TAB2/HDAC3
tion with the KAI1 promoter. Indeed, after IL-1 stimula- complex (Figures 4A and 4B). Moreover, Tip60 was not
tion, MEKK1 was detected on the promoter, consistent recruited after IL-1 stimulation; instead, two other co-
with the hypothesis that phosphorylation of TAB2 by activators, CBP and p/CIP, were recruited to the ICAM-1
MEKK1 occurs on target genes in the nucleus (Figure promoter, revealing distinct molecular strategies for ac-
3C). In contrast, other protein kinases, including MEK1, tivation of the ICAM-1 promoter compared to the KAI1
Akt1/2, PKA, Rsk1, and CaMKIV, were not detected on promoter (Figure 4C and data not shown). On the IL-8
the KAI1 promoter by ChIP assay (Figure 3C and data not promoter, many coactivator and chromatin remodeling
complex molecules, including p160 factors, p300/CBP,shown). Further, HDAC3 was the only HDAC detected,
Cell
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Figure 3. Identification of a p50-Dependent Target Gene, KAI1, Recruiting N-CoR/TAB2/HDAC3 Complex
(A) TAB2 interacts with p50 but not p65 in the presence of N-CoR. A GST/TAB2 fusion protein was incubated with 35S-labeled p50 or p65
from rabbit reticulocyte lysate alone or with unlabeled in vitro translated N-CoR.
(B) Intracellular interactions between p50 and N-CoR or TAB2 shown in 293 cell extracts immunoprecipitated with either anti-TAB2 or anti-
N-CoR IgG and coprecipitated were detected with anti-p50 IgG.
(C) Chromatin immunoprecipitation (ChIP) assay on KAI1 promoter. Occupancy of KAI1 promoter by p50, N-CoR/TAB2/HDAC3, Bcl3, Tip60,
acetylated histones H3 and 4, phosphorylated histone H3, RNA polymerase (Pol II), MEKK1, TRRAP, and other factors at the indicated times
after IL-1 treatment in 293 cells. Schematic representation shows the dynamics of cofactor occupancy on the KAI1 promoter.
(D) RNA blot and RT-PCR of KAI1 and -actin transcripts following IL-1 stimulation.
(E) Overexpression of Tip60 HATmut causes the failure of Pol II binding and acetylation of histones H3 and H4 after IL-1 treatment for 1 hr.
(F) Overexpression of TAB2 S419/423A blocks dismissal of the N-CoR complex and gene activation events in response to IL-1 for 1 hr.
p/CAF, Brg1, and PBP were recruited (Figure 4B and repression by specific DNA binding transcription factors
requires TAB2 and whether all repression is relieved.data not shown), similar to factors recruited on the estro-
gen receptor-dependent genes. These indicate different Surprisingly, treatment with IL-1 did not have a signifi-
cant effect on the retinoic acid (RA)-dependent switchpatterns of coactivator recruitments by NF-B-regu-
lated promoters activated by p50/p65 heterodimers from repression to ligand-dependent activation of a lacZ
reporter driven by retinoic acid response element se-(Figure 4C).
quences (Figure 5A). Consistent with the role of N-CoR,
single-cell nuclear microinjection of IgG against N-CoR,Function of IL-1 Signaling to Selectively Relieve
N-CoR-Mediated Repression as well as HDAC1 or HDAC2, largely relieved the repres-
sion by unliganded RAR (Figure 5B). N-CoR as well asExport of the majority of nuclear N-CoR in response to
IL-1 raises the question of whether all N-CoR-mediated HDAC2, but not TAB2, were detected on the RAR pro-
N-CoR Complex Exchange and -APP
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Figure 4. ChIP Analysis of IL-1-Induced Cofactor Association with the ICAM-1 and IL-8 Promoter
(A) Recruitment patterns of p50, p65, and different coactivators on ICAM-1 promoter in 293 cells treated with IL-1.
(B) Identical analysis was performed on the IL-8 promoter.
(C) Schematic representation showing ICAM-1 and IL-8 promoter occupancy by various coactivators induced by IL-1.
moter, and the IL-1 treatment did not cause release adhesion and is capable of interacting with many plasma
membrane receptors (Maecker et al., 1997). For exam-from the RAR promoter (Figure 5C). Similarly, IL-1
treatment had no significant effect on T3R-mediated re- ple, its interactions with the EGF receptor causes en-
hanced ligand-dependent downregulation of the EGFpression (Figure 5D). We next evaluated effects of IL-
1 on antagonist bound ER. The estrogen receptor receptor (Odintsova et al., 2000). The p50-dependent
recruitment of Tip60 to the KAI1 promoter in responseinteracts with N-CoR to repress transcription in the pres-
ence of tamoxifen (4-OHT) (Smith et al., 1997; Lavinsky to IL-1 raised a potential connection between the ac-
tions of APP and p50-regulated genes, because Tip60et al., 1998). A ChIP assay was therefore performed on
the pS2 promoter in the MCF7 cell line (Shang et al., has been shown to exist in a complex with AICD and
Fe65 (Cao and Sudhof, 2001). In the presence of high2000). Using the ChIP assay, promoter occupancy by
factors including N-CoR, HDAC2, and mSin3 was ob- levels of Fe65, both AICD and Fe65 are translocated
into the nucleus (Kimberly et al., 2001). The C terminusserved as expected (Jepsen et al., 2000; Shang et al.,
2000); unexpectedly, however, recruited factors in- of APP, Fe65, and Tip60 can form a transcriptionally
active complex with Gal4/Tip60 and an UAS-dependentcluded TAB2 and HDAC3, whether as a distinct or an
associated complex (Figure 5E). Microinjection of IgGs reporter in transiently transfected cells (Cao and Sudhof,
against HDAC1, HDAC2, or N-CoR fully relieved the fail- 2001). Although these findings suggested a transcrip-
ure of activation by 4-OHT bound ER (Figure 5F), con- tional consequence of APP cleavage, potential physio-
firming the importance of these components on the pS2 logical target genes were not identified.
promoter. However, following pretreatment with IL-1 We therefore tested the hypothesis that p50-depen-
for 2 hr, 4-OHT mediated activation of a reporter under dent transcription units, such as KAI1, might serve as
control of an estrogen receptor response element, while biological targets for the AICD/Fe65/Tip60 complex. On
microinjection of anti-TAB2 IgG that blocks N-CoR/ cotransfection, even without IL-1 stimulation, all three
TAB2 export abolished the IL-1-dependent effect (Fig- components of the trimeric complex AICD/Fe65/Tip60
ure 5G). Thus, even though a majority of N-CoR is ex- were recruited to the KAI1 promoter, with the presence
ported in response to IL-1, there is apparently sufficient of AICD assessed using an antibody specifically di-
N-CoR in complexes not containing TAB2 and/or SMRT rected to the C terminus of APP (Figure 6A). In compari-
to maintain RAR repression, but not 4-OHT effects on son, on the ICAM-1 and IL-8 promoters (Figure 6B), no
ER function. components of the trimeric complex appeared before
or after IL-1 treatment, revealing that the association
with the KAI1 promoter was specific. Only when all threeThe KAI1 Promoter Is a Target
molecules were coexpressed did we detect signals onfor an AICD/Fe65/Tip60 Complex
the KAI1 promoter (Figure 6C). Western blot analysisKAI1 is a tetraspanin, a cell surface molecule acting as
a tumor metastasis suppressor that functions in cell confirmed effective expression of each component re-
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Figure 5. Functions of IL-1 Signaling to Relieve N-CoR-Mediated Repression
(A) Treatment with the RA resulted in a switch from repression to ligand-independent activation of a lacZ reporter gene driven by DR5
sequences; treatment with IL-1 did not have any significant effect on repression.
(B) Single-cell nuclear microinjection of purified IgG against N-CoR, HDAC1, or HDAC2 largely relieved the repression by unliganded RAR.
(C) ChIP assay on RAR promoter detected N-CoR and HDAC2 but not TAB2. N-CoR was not released from the promoter after IL-1 treatment.
(D) IL-1 did not exert any significant effects on T3R-mediated repression.
(E) ChIP assay on the pS2 promoter shows promoter occupancy by N-CoR/HDAC2/mSin3 complex, as well as N-CoR/TAB2/HDAC3 complexes
in 4-OH-tamoxifen (4-OHT)-treated cells.
(F) Microinjection of IgG against HDAC1, HDAC2, or N-CoR fully relieved the repression by 4-OHT bound estrogen receptor .
(G) Pretreatment with IL-1 abolished 4-OHT-mediated repression of a reporter containing ERE, and nuclear microinjection of anti-TAB2 IgG
blocked IL-1-dependent derepression. Results are mean  SEM 200 cells injected for each data point.
gardless of the combination of factors expressed (data APP also abolished this ternary complex (Figure 6E).
Therefore, histone acetyltransferase function of Tip60not shown). Expression of the full trimeric complex ap-
peared to replace the N-CoR/TAB2/HDAC3 complex appears, directly or indirectly, to be a required compo-
nent of ternary complex formation in the nucleus.that mediates a repressed status and was accompanied
by transcriptional activation, with recruitment of RNA
Pol II and acetylation of histones H3/H4 (Figure 6D). Upregulation of Both Protein and mRNA Levels
of APP, Fe65, Tip60, and KAI1In contrast to IL-1-dependent activation (Figure 3C),
TRRAP was not recruited to the KAI1 promoter (Figure in APP-Overproducing Mice
Because enhanced expression of all three components6D), indicating that the Tip60 complex is distinct from
that recruited following IL-1 stimulation. of the AICD/Fe65/Tip60 complex are required for tran-
scriptional activation of the KAI1 promoter, we next de-Expression of an APP mutant harboring a deletion of
the YENPTY sequence that interacts with Fe65 (APPmut) termined whether this might occur in vivo by analyzing
both the mRNA and protein levels of all three factors in(Borg et al., 1996) or a Tip60 HAT mutant (Tip60 HATmut)
(Ikura et al., 2000) prevented recruitment of this complex the APP-overproducing transgenic mice that develop
amyloid pathology at 9 months (Mucke et al., 2000).on the KAI1 promoter in transfected cells (Figure 6D).
Unexpectedly, substitution of wild-type Tip60 with Tip60 Unexpectedly, in the APP-overexpressing transgenic
mice, analyzed at 4 weeks of age, the protein levelsHATmut also prevented the binding of the trimeric com-
plex, maintaining the actions of the repression machin- of APP, Fe65, and Tip60 were all dramatically increased,
indicating that by an as yet unknown feed-forwardery (Figure 6D). Surprisingly, when we performed a coim-
munoprecipitation experiment, comparing formation of mechanism, enhanced APP levels lead to upregulation
of both Fe65 and Tip60 (Figure 6F). Further, we foundthe trimeric complex by wild-type Tip60 or Tip60 HATmut,
we found that lack of the acetyltransferase function of a marked increase of both KAI1 protein (Figure 6F) and
mRNA expression (Figure 6G) in transgenic mice asTip60 completely abolished formation of the trimeric
complex, as evidenced by failure of coimmunoprecipita- compared to their littermate controls (Figure 6G). These
increased levels can lead to a complex in the CNS,tion of Tip60 or Fe65 (Figure 6E and data not shown).
As expected, loss of the Fe65 interaction domain of based on immunoprecipitation of Fe65 and Tip60 by
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Figure 6. Recruitment of APP/Fe65/Tip60 Complex on the KAI1 Promoter and Analysis of APP-Overproducing Transgenic Mice
(A) ChIP assays on the KAI1 promoter in the untransfected cells (control) and cells transfected with APP, Fe65, and Tip60 expression vectors
at indicated times after addition of IL-1.
(B) ChIP assay on the ICAM-1 and IL-8 promoters fail to detect APP, Fe65, and Tip60.
(C) ChIP assay after cotransfection of all combinations of APP/Fe65/Tip60. Only when all three molecules were expressed were signals
detected on the promoter.
(D) Replacement of the N-CoR/TAB2/HDAC3 complex by an AICD/Fe65/Tip60 complex. This replacement was not detected when either an
APP mutant that does not interact with Fe65 or a Tip60 HATmut was cotransfected instead of wild-type proteins. TRRAP is not recruited to
the KAI1 promoter.
(E) Immunoprecipitation experiments from 293 cells following cotransfection show that Tip60 HATmut impairs formation of the trimeric complex.
(F) Immunoblotting of extracts from 4-week-old brains from littermates representing control for APP-overexpressing transgenic mice were
used to evaluate protein levels of APP, Fe65, Tip60, and KAI1.
(G) mRNA levels for APP, Fe65, Tip60, and KAI1 were compared between transgenic mice () and their littermate controls (	).
(H) APP coimmunoprecipitated brain extracts from 4-week-old transgenic mice containing Fe65 and Tip60.
(I) ChIP assay performed on 4-week-old CNS transgenic mice reveals recruitment of AICD/Fe65/Tip60 to the KAI1 promoter, but not the ICAM1
promoter.
(J) Effect of treatment with either a -secretase inhibitor (2.5 
M) or ibuprofen (500 
M) for 12 hr. ChIP assay was performed on the KAI1
promoter after treatment with either the -secretase inhibitor or ibuprofen, both of which blocked recruitment of the trimeric complex on the
KAI1 promoter in transfected cells. Similar results were obtained using ibuprofen (5 
M) or naproxen (500 
M).
(K) Treatment with either -secretase inhibitor or ibuprofen did not have any significant effect on protein expression levels as assessed by
immunoblotting.
APP using nuclear extracts from brain (Figure 6H). ChIP Fe65/Tip60 ternary complex, consistent with the release
of membrane-associated C-terminal fragment of APPanalysis performed on the CNS of 4-week-old transgenic
mice revealed binding of AICD/Fe65/Tip60 on the KAI1 by -secretase activity (Pinnix et al., 2001).
Treatment with a -secretase inhibitor L-685,458 (Lipromoter (Figure 6I). Together these data suggest that
the KAI1 gene is a direct, potentially functionally signifi- et al., 2000) essentially abolished the appearance of
the AICD/Fe65/Tip60 signal on the KAI1 promoter incant in vivo target gene of the overexpressed AICD/
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Figure 7. Integration of Signaling Responses
by IL-1-Induced Derepression and by a
Physiological/Pathological Mechanism of
Derepression/Activation
IL-1 signaling activates MEKK1-dependent
translocation of an N-CoR/TAB2/HDAC3
complex based on phosphorylation of a spe-
cific residue on TAB2, causing derepression
of p50-dependent transcription units, exem-
plified by KAI1. However, antagonist actions
of tamoxifen are lost upon IL-1 stimulation,
indicating a specific program of derepression
integrated by this signaling pathway. Unex-
pectedly, -secretase-dependent C-terminal
cleavage of APP leads to formation of a dis-
tinct AICD/Fe65/Tip60 complex. This complex,
formation of which requires Tip60 HAT func-
tion, in transfected cells displaces N-CoR/
TAB2/HDAC3, activating the KAI1 promoter
and providing a potential mechanism for
pathophysiological and perhaps physiologi-
cal regulation of gene expression in the CNS.
transfected cells (Figure 6J). Epidemiological studies function) as well as to activate the p50/p65 targets (cyto-
plasmic function) (Takaesu et al., 2000).have suggested that use of nonsteroidal antiinflamma-
We have provided evidence indicating that the molec-tory drugs (NSAIDs) is associated with lower risk of
ular basis of IL-1-dependent nuclear export of the nu-Alzheimer’s disease, possibly by inhibiting the inflam-
clear N-CoR likely represents a MEKK1-dependentmatory response in brain (reviewed in Wyss-Coray and
phosphorylation of TAB2 in the nucleus, putatively caus-Mucke, 2000). Treatment with NSAIDs can selectively
ing an allosteric alteration that exposes the TAB2 nu-reduce the levels of amyloidogenic A42 (Weggen et
clear export signal. Thus, MEKK1 might also serve toal., 2001) and decrease amyloid pathology and levels of
integrate signal transduction pathways, both in the nu-IL-1 in brains of APP transgenic mice (Lim et al., 2000).
cleus and in the cytoplasm (Lee et al., 1997), leading toWe find that ibuprofen at both high and low concentra-
activation of NF-B-dependent genes (Figure 7).tions largely blocked recruitment of the AICD/Fe65/
Tip60 complex on the KAI1 promoter in transfected cells
IL-1-Dependent Export of an N-CoR Complex(Figure 6J and data not shown). Further, binding of the
Causes Gene- and Factor-Selective DerepressionNCoR/TAB2/HDAC3 corepressor complex was restored
The ability of IL-1 to mediate the export of a specific(Figure 6J). Similar results were obtained with naproxen
N-CoR complex raised the question of whether all, or(data not shown), suggesting that NSAIDs have second-
only a subset, of N-CoR-dependent genes would beary activity that inhibits the trimeric transcriptional acti-
derepressed. Our data suggest that only a subset ofvation complex. Treatment with either the -secretase
genes exhibiting N-CoR/SMRT-dependent repression isinhibitor or ibuprofen did not alter the expression levels
derepressed in response to the IL-1 signal. The obser-of APP, Fe65, and Tip60 protein in the transfected cells
vation that IL-1 can antagonize N-CoR-mediated re-(Figure 6K and data not shown).
pression by tamoxifen bound estrogen receptor, which
recruits both the N-CoR/mSin3/ HDAC1, 2 and N-CoR/
Discussion TAB2/HDAC3 complexes, has intriguing implications for
therapeutic and pharmacological application of anties-
TAB2 Regulates Translocation of N-CoR trogens in breast cancer. However, in accord with the
In this manuscript, we have defined a molecular mecha- finding that TAB2 is not recruited to retinoic acid or
nism that links inflammation to derepression of a spe- thyroid hormone receptors, it proves not to be required
cific subset of NF-B-regulated genes via control of a for N-CoR-mediated repression by either unliganded re-
previously unknown stable N-CoR complex (Figure 7). tinoic acid or thyroid hormone receptors. These data
This N-CoR/TAB2/HDAC3-containing complex binds to suggest that despite the large percentage of N-CoR
p50-regulated target genes and undergoes a nuclear to exported, there was not sufficient loss of the distinct
cytoplasmic translocation in response to IL-1 signal- N-CoR complexes involved in retinoic acid receptor-
ing. TAB2 itself enhances N-CoR-dependent repression, dependent repression of target genes, such as RAR,
but the apparently critical function of TAB2 is to regulate to result in derepression upon stimulation of the IL-1
IL-1-mediated translocation of the N-CoR complex out signal transduction pathway. It may also be true that
of the nucleus. TAB2 thus seems to have dual roles SMRT can fulfill this role, suggesting gene-specific roles
upon activation of the NF-B pathway, serving to both of distinct N-CoR and SMRT complexes in transcrip-
tional repression.derepress p50-dependent transcription units (nuclear
N-CoR Complex Exchange and -APP
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Mechanisms of p50-Dependent Gene Activation changes (Mucke et al., 2000), unexpectedly exhibit in-
creased expression of both Fe65 and Tip60 in the CNS.Our data indicate that KAI1/CD82 is an IL-1-induced
NF-B target gene based on binding of p50 homodimer. All three components of the AICD/Fe65/Tip60 complex
are unexpectedly induced, forming a complex bindingUnder unstimulated conditions, p50, but not p65, was
detected on the KAI1 promoter, while after IL-1 stimu- to the KAI1/CD82 promoter. This complex is capable
of displacing the N-CoR/TAB2/HDAC3 complex in thelation, the level of promoter-associated p50 remained
constant, without any binding by p65. Bcl3 occupies the absence of an IL-1 signal and causing target gene
activation. KAI1 itself provides a potentially intriguingKAI1 promoter in the presence or absence of IL-1, and
several independent studies have suggested that Bcl3 transcriptional target of APP overexpression. As many
cell surface receptors and cell adhesion molecules thatcan act as a bridging factor linking NF-B to nuclear
coregulators (Fujita et al., 1993). Tip60 has been sug- regulate cytoskeletal functions are impacted by the tet-
raspanin KAI1/CD82 (Maecker et al., 1997), it is temptinggested to be a binding partner of Bcl3, enhancing Bcl3/
p50-activated transcription through a NF-B binding site to speculate that expression of KAI1 might contribute
to later pathological events.(Dechend et al., 1999).
Thus, the recruitment of Tip60 to KAI1/CD82 promoter Remarkably, the acetyltransferase function of Tip60
is required to form the ternary complex that can displaceafter IL-1 treatment, possibly requiring Bcl3, appears
to be of functional importance to activation of the gene, an N-CoR/TAB2/HDAC3 corepressor complex. In addi-
tion to autoacetylation of Tip60, we find increased levelswhich is accompanied by acetylation of histones H3/
H4. Tip60 has been identified as a component of a of acetylated Fe65 in the trimeric complex (data not
shown), suggesting that acetylation of Fe65 might bemultimeric protein complex containing histone acety-
lase, ATPase, DNA helicase activity, and structural DNA a regulatory component of ternary complex formation.
These data provide a striking example of acetylationbinding activity, which links it to DNA repair function
(Ikura et al., 2000). In the case of KAI1/CD82 promoter, as a critical regulatory aspect of coactivator complex
assembly, required for specific gene activation events.Tip60 appears to be recruited as a component of a
TRRAP-containing complex, likely distinct from the puri- Since the transcriptional activation of KAI1 by AICD/
Fe65/Tip60 is abolished by both the NSAIDs ibuprofenfied repair complex, although the precise complement
of corecruited factors remains to be defined. The Tip60 and naproxen with restoration of the binding of the
NCoR/TAB2/HDAC3 complex on the promoter, we pos-HAT function appears to be required, directly or indi-
rectly, for effective gene activation, as Tip60 HATmut abol- tulate that NSAIDs may act at some step(s) distal to
generation of AICD by an as yet unknown mechanism.ishes histone H3 and H4 acetylation and recruitment of
Pol II. The observed acetylation of histones H3/H4 during Together, these data are consistent with a model in
which IL-1 acts physiologically to cause dismissal ofIL-1-stimulated KAI1 transcription could reflect direct
acetylation by Tip60 in a promoter-specific fashion, or a specific N-CoR corepressor complex and recruitment
of a Tip60-containing coactivator complex resulting init could reflect recruitment of an as yet unidentified his-
tone acetyltransferase. In contrast to KAI1, examination activation of p50 target genes. The AICD/Fe65/Tip60
trimeric complex can similarly displace the N-CoR com-of two other NF-B-regulated genes that recruit p50/
p65 heterodimers revealed no recruitment of the N-CoR/ plex, derepressing gene targets such as KAI1/CD82
(Figure 7), providing a potential transcriptional activationTAB2/HDAC3 complex. The identification of a large
number of transcriptional coactivators and corepres- strategy that we speculate may underlie specific as-
pects of APP function, both in normal physiology andsors, capable of interacting with distinct DNA bound
transcription factors, has raised questions regarding in Alzheimer’s disease.
their potential specificity and complementarity in gene
regulation events. We find that the NF-B-regulated Experimental Procedures
genes examined appear to recruit distinct coactivator
Materials and Reagentsmachinery during gene activation events in response to
Anti-TAB2 IgG was generated against bacterially expressed TAB2IL-1, which is in contrast to the apparently more uni-
and affinity purified (Affinity BioReagents). Anti-APP C-terminal anti-
form, ligand-dependent recruitment of many coactivator body (CT-15) has been described previously (Koo and Squazzo,
complexes in estrogen receptor-regulated genes (Shang 1994). The following antibodies were obtained from Santa Cruz Bio-
et al., 2000). technology: anti-HDACs, TBL1, p50, p65, Bcl3, Tip60, MEKK1,
MEK1, Akt1/2, CBP, p300, p/CIP, BRG1, SRC1, p/CAF, GRIP-1,
mSin3A, phospho-histone H3, and c-myc (9E10). Anti-Fe65 antibodyImplications of Gene Activation
is a gift from Dr. P. Greengard. The following commercially available
by APP/Fe65/Tip60 Complex antibodies were used: antiacetylated histone H3 and H4 (Upstate
-secretase cleavage of APP releases not only A from Biotechnology), anti-RNA polymerase II antibodies (Berkeley Anti-
the membrane but also the intracellular fragment AICD, body Company), and anti-ER (NeoMarkers). Fluorogenic histone
deacetylase substrate (Boc-Lys (Ac)-AMC) was from Calbiochem.which was identified only very recently because of its
APP transgenic mice (J9 line) of 4–16 weeks were analyzed.instability (Passer et al., 2000). A number of investigators
have speculated that by analogy to signaling by NICD
Yeast Two-Hybrid Screening and Yeast Two-Hybridderived from Notch 1 receptor (Kao et al., 1998;
Interaction AssaysSchroeter et al., 1998; De Strooper et al., 1999), the
Baits were expressed as fusions with the GAL4 DNA binding domaincorresponding AICD may also function in signal trans-
(pGBKT7), and library and target plasmid were expressed as fusions
duction. In this manuscript, we have shown that trans- with the GAL4 activation domain (pGAD10) (Clontech, Matchmaker
genic mice overexpressing APP, which develop age- two-hybrid system). -galactosidase units were calculated using
standard methods.related amyloid deposits and associated pathologic
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Indirect Immunofluorescence Analysis Fujita, T., Nolan, G.P., Liou, H.C., Scott, M.L., and Baltimore, D.
(1993). The candidate proto-oncogene bcl-3 encodes a transcrip-and Deconvolution Microscopy
Cells were grown on coverslips and washed with PBS three times. tional coactivator that activates through NF-B p50 homodimers.
Genes Dev. 7, 1354–1363.Cells were then fixed, washed, and permeabilized. Double-stained
cells were incubated with affinity-purified anti-N-CoR IgG and anti- Glass, C.K., and Rosenfeld, M.G. (2000). The coregulator exchange
TAB2 IgG overnight and incubated for 2 hr with secondary antibod- in transcriptional functions of nuclear receptors. Genes Dev. 14,
ies, followed by three washes in PBS. Fluorescent slides were im- 121–141.
aged using deconvolution microscopy (UCSD).
Guenther, M.G., Lane, W.S., Fischle, W., Verdin, E., Lazar, M.A., and
Shiekhattar, R. (2000). A core SMRT corepressor complex containing
Single-Cell Nuclear Microinjection Assays
HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes
Microinjection assays were carried out as previously described (Jep-
Dev. 4, 1048–1057.
sen et al., 2000). Each experiment was performed on three indepen-
Heinzel, T., Lavinsky, R.M., Mullen, T.M., Soderstrom, M., Laherty,dent cover slips consisting of 1000 cells, with 300 cells injected.
C.D., Torchia, J., Yang, W.M., Brard, G., Ngo, S.D., Davie, J.R., etWhere no experimental antibody was used, preimmune rabbit or
al. (1997). A complex containing N-CoR, mSin3 and histone deacety-guinea pig IgG was coinjected, allowing the unambiguous identifica-
lase mediates transcriptional repression. Nature 387, 43–48.tion of injected cells in addition to serving as a preimmune control.
Horlein, A.J., Naar, A.M., Heinzel, T., Torchia, J., Gloss, B., Kuro-
kawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C.K., andChromatin Immunoprecipitation Assays
The chromatin immunoprecipitation assay was conducted as pre- Rosenfeld, M.G. (1995). Ligand-independent repression by the thy-
roid hormone receptor mediated by a nuclear receptor co-repressor.viously described (Jepsen et al., 2000; Shang et al., 2000), with
average size of sheared fragments about 300–1000 bp. For PCR, Nature 377, 397–404.
1 
l from a 50 
l DNA extraction and 25 cycles of amplification were Ikura, T., Ogryzko, V.V., Grigoriev, M., Groisman, R., Wang, J., Hori-
used. koshi, M., Scully, R., Qin, J., and Nakatani, Y. (2000). Involvement
of the TIP60 histone acetylase complex in DNA repair and apoptosis.
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